The Journal of Headache and Pain 2025 Jul 2;26(1):153. doi: 10.1186/s10194-025-02086-0. M Lanteri-Minet , C Casarotto, O Bretin, C Collin, M Gugenheim, V Raclot, A Cases, P A Squara, W Aissani, A Saighi, H Lefebvre Abstract Background: The most used treatments for migraine attacks are triptans, yet a considerable proportion of
Validation of an 8-item self-administered questionnaire for assessing migraine-related sensory hypersensitivities (MHQ-8)
The Journal of Headache and Pain 2025 May 26;26(1):128. doi: 10.1186/s10194-025-02067-3. François Gabrielli , Melissa Zuel , Camille Magaud , Sophia Sickout-Arondo , Bruno Pereira , Jérémie Dassa , Solène De Gaalon , Geneviève Demarquay , Anne Donnet , Anne Ducros , Pierric Giraud , Evelyne Guégan-Massardier , Christian Lucas , Jérôme Mawet